GlassScriptPhysician profile
Wajde Dabah
NPI 1194024984
$37,203.47
in general payments reported to CMS, 2019-2025
69 companies · $2,917 in 2025
The $2,917 reported for 2025 was more than what 88% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,659 · 2020: $4,019 · 2021: $8,266 · 2022: $5,215 · 2023: $2,008 · 2024: $5,119 · 2025: $2,917.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,044.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,035.66 | 2020-2025 | Proclaim, Eterna, Ionicrf |
| Electronic Waveform Lab, INC. | $5,729.95 | 2019-2022 | |
| Boston Scientific Corporation | $3,204.42 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Intracept |
| Spinal Simplicity, LLC | $2,332.54 | 2021-2024 | Ha Minuteman G3-R |
| Abbvie INC. | $2,116.28 | 2019-2025 | Ubrelvy, Botox, Qulipta |
| Nevro Corp. | $1,920.22 | 2019-2022 | |
| Vertos Medical, INC. | $1,514.02 | 2019-2024 | Mild Device Kit |
| Biotronik Nro, INC. | $1,260.38 | 2023-2025 | Prospera, Biotronik |
| Relievant Medsystems, INC. | $1,034.66 | 2022-2023 | Intracept |
| Painteq LLC | $997.82 | 2022-2024 | Painteq |
| Amgen INC. | $949.15 | 2019-2025 | Otezla, Enbrel, Otezla |
| Si-Bone, INC. | $661.99 | 2019-2025 | |
| Ucb, INC. | $641.61 | 2019-2024 | Cimzia |
| Medtronic, INC. | $617.18 | 2023-2025 | Intellis Adaptivestim, Venaseal, Osteocool Rf Ablation System |
| Collegium Pharmaceutical, INC. | $611.72 | 2019-2025 | Belbuca |
Show all 69 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $494.13 | 2019-2021 | |
| Janssen Biotech, INC. | $390.52 | 2019-2022 | |
| Vertiflex, INC. | $385.39 | 2019 | |
| Stryker Corporation | $340.44 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $333.06 | 2019-2023 | |
| Fidia Pharma USA INC. | $331.65 | 2019-2025 | Hymovis, Triluron, Hyalgan |
| Lilly USA, LLC | $310.92 | 2019-2021 | |
| Ibsa Pharma INC. | $299.43 | 2021-2025 | Tirosint, Tirosint, Licart |
| Mml US, INC. | $294.07 | 2024-2025 | Reactiv8 |
| Neuronetics, INC. | $279.17 | 2019-2022 | |
| Horizon Therapeutics Plc | $206.08 | 2019-2020 | |
| Smith+Nephew, INC. | $190.92 | 2020 | |
| Mallinckrodt Hospital Products INC. | $175.06 | 2021-2023 | Acthar |
| Assertio Therapeutics, INC. | $174.26 | 2019-2020 | |
| Allergan, INC. | $165.88 | 2020-2022 | |
| Spr Therapeutics, INC | $143.34 | 2022-2025 | Sprint Pns System |
| Stimwave Technologies Incorporated | $134.78 | 2020-2022 | |
| Grt US Holding, INC. | $133.35 | 2021-2022 | |
| Almatica Pharma LLC | $129.28 | 2021-2023 | Gralise |
| Janssen Pharmaceuticals, INC | $115.19 | 2023-2024 | Spravato |
| Pacira Therapeutics, INC. | $112.12 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $109.66 | 2024-2025 | |
| Nalu Medical, INC. | $108.12 | 2021-2023 | Nalu Neurostimulation System |
| Averitas Pharma INC. | $99.04 | 2023-2024 | Qutenza |
| Bausch Health US, LLC | $83.98 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $82.79 | 2021-2024 | |
| Depuy Synthes Sales INC. | $76.61 | 2022-2025 | Orthovisc, Monovisc |
| Daiichi Sankyo INC. | $68.31 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.83 | 2021-2024 | Cyltezo |
| Zyla Life Sciences, INC. | $62.24 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $53.13 | 2023 | |
| Glaxosmithkline, LLC. | $51.57 | 2020-2022 | |
| Valinor Pharma, LLC | $43.51 | 2025 | Movantik |
| Saluda Medical Americas, INC. | $41.98 | 2025 | Evoke |
| Orthogenrx INC. | $41.88 | 2020-2021 | |
| Pfizer INC. | $41.80 | 2019 | |
| Antares Pharma, INC. | $34.41 | 2020 | |
| Arbor Pharmaceuticals, INC. | $31.37 | 2019-2021 | |
| Orthofix Medical, INC. | $31.37 | 2021 | |
| Scilex Pharmaceuticals INC. | $30.41 | 2019 | |
| Lundbeck LLC | $27.85 | 2023 | Vyepti |
| Kowa Pharmaceuticals America, INC. | $27.80 | 2023 | Seglentis |
| Axsome Therapeutics, INC. | $26.19 | 2025 | Symbravo |
| Celgene Corporation | $23.02 | 2019 | |
| Avanos Medical | $22.34 | 2022 | |
| Radius Health, INC. | $20.39 | 2019 | |
| Asahi Intecc USA, INC. | $20.32 | 2024 | Peripheral Vascular |
| Genzyme Corporation | $19.23 | 2019 | |
| Curonix LLC | $18.18 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Mallinckrodt Enterprises LLC | $16.69 | 2019 | |
| Supernus Pharmaceuticals, INC. | $16.52 | 2019 | |
| Lenoss Medical INC | $16.17 | 2025 | Osteopearl |
| Uswm, LLC | $15.85 | 2021 | |
| Hikma Pharmaceuticals USA | $11.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wajde Dabah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.